Renal Cancer - Results from #7660

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor - Abstract June 11, 2013

Influence of body mass index, smoking, and blood pressure on survival of patients with surgically-treated, low stage renal cell carcinoma: A 14-year retrospective cohort study - Abstract June 11, 2013

Results of targeted therapies for m1 renal cell carcinoma: Our experience - Abstract June 10, 2013

Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component - Abstract June 10, 2013

Sunitinib does not accelerate tumor growth in patients with metastatic renal cell carcinoma - Abstract June 7, 2013

Progression, interobserver agreement, and malignancy rate in complex renal cysts (≥Bosniak category IIF) - Abstract June 7, 2013

A new modified schedule of sunitinib for metastatic renal cell carcinoma: A retrospective analysis - Abstract June 7, 2013

Five-year survival in patients with cytokine-refractory metastatic renal cell carcinoma treated with axitinib - Abstract June 7, 2013

Transition of organizational category on renal cancer - Abstract June 6, 2013

Management of metastatic renal cell carcinoma progressed after sunitinib or another antiangiogenic treatment - Abstract June 6, 2013

A comparison of pathologic outcomes of matched robotic and open partial nephrectomies - Abstract June 6, 2013

Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients - Abstract June 6, 2013

Clear cell renal cell carcinoma: Discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT - Abstract June 5, 2013

Prognostic models and factors for patients with renal-cell carcinoma: A survey on their use among urologists - Abstract June 5, 2013

13-Year-old tuberous sclerosis patient with renal cell carcinoma associated with multiple renal angiomyolipomas developing multifocal micronodular pneumocyte hyperplasia - Abstract June 5, 2013

Therapeutic challenges in advanced renal cell carcinoma - Abstract June 5, 2013

Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk - Abstract June 5, 2013

Thulium laser supported nephron sparing surgery for renal cell carcinoma - Abstract June 5, 2013

Oral and intravenously administered mTOR inhibitors for metastatic renal cell carcinoma: Pharmacokinetic considerations and clinical implications - Abstract June 5, 2013

Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors - Abstract June 5, 2013

Page 384 of 456